Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 9, 2009

View Archived Issues

Weight loss seen in one-year studies of velneperit in obese subjects

AMPA receptor potentiator PF-4778574 safe and active in preclinical models of cognition

NOP receptor agonist SCH-655842 exhibits anxiolytic activity in preclinical models

SUVN-623 shows promising activity in animal models of cognition

Nicotinic alpha4beta2 receptor modulator A-969933 alters the stimulant effects of nicotine

Results reported for phase I clinical trial of new slow-release metadoxine

Dong-A PharmTech starts phase III trials of udenafil in men with erectile dysfunction

FDA grants orphan drug designation to Sunesis' voreloxin for acute myeloid leukemia

FDA advisory committee to review Theratechnologies' NDA for tesamorelin

Ligand Pharmaceuticals and Pfizer extend research collaboration for JAK3

InterMune submits NDA to FDA for pirfenidone in idiopathic pulmonary fibrosis

Immunovaccine and Canadian military collaborate to develop anthrax vaccine

FDA approves labeling update for Reyataz to include 96-week CASTLE data

Dipeptidyl peptidase IV inhibitors claimed by Taiwanese scientists as antidiabetics

Helix completes enrollment in phase II topical interferon alpha-2b trial

Raf kinase inhibitors disclosed by Wyeth for the treatment of cancer

BMS describes serine protease inhibitors for treating thromboembolic disorders

ERYtech Pharma starts pivotal trial of Graspa in acute lymphoblastic leukemia

FDA approves Gloucester's Istodax for cutaneous T-cell lymphoma

FDA approves Pennsaid topical solution for osteoarthritis of the knee

Theravance and Astellas Pharma launch telavancin in the U.S.

Novexel initiates phase II clinical trial of NXL-103 in bacterial skin infections

Shire launches Intuniv in the U.S. for ADHD in children and adolescents

Phase I study finds potential for rontalizumab in systemic lupus erythematosus

AIDS Vaccine meeting snapshots: Phase I and II trials of candidate vaccines

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...